The multifunctional APE1 protein is required for tumor progression and is associated with cancer resistance. It is shown that APE1 presents structural elements that function in distinct cellular roles, highlighting the molecular determinants of the multifunctional nature of this protein and providing the basis for a new role of the C65 residue.
Highlights APE1 is overexpressed in colorectal cancer The APE1-endonuclease inhibitor (Compound #3) promotes p53 activation in HCT-116 colon cancer cell line. Compound #3 triggers p53-mediated effects on cell metabolism in HCT-116 colon cancer cell line. Compound #3 affects mitochondrial activity and sensitises cells to genotoxic treatment in a p53-dependent manner. 3D organoids derived from colorectal cancer patients are susceptible to Compound #3 in a p53-status correlated manner. Bioinformatics analyses support the hypothesis to target mitochondrial function in cancer cells through APE1-endonuclease inhibitors. Further studies are needed to test the possibility to target the endonuclease activity of APE1 in colorectal cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.